Keppra (levetiracetam) - Important Safety Information from UCB (Pharma) Ireland Limited as approved by the HPRA

Notice type: 3rd Party Publications

Date: 25/11/2016

 

Problem Or Issue:

Important Safety Information communication from UCB (Pharma) Ireland Limited: Levetiracetam containing products 100 mg/ml oral solution presentations: Risk of medication errors associated with overdose.

 

Important Safety Information - Keppra (levetiracetam)



« Back